Botulinum toxin type A attenuates trigeminal neuralgia-like pain by suppressing CGRP release and modulating NaV1.7-associated signaling. Yao M-H, Chen H-C, Zhang X-Y, Zhou S-W, Li C-X, Lu Y-Y, Liao Z-R, Wang L, Zhang R-H, Jing Y-H J Headache Pain. 2026 Aug 10; 27(1). PMID: 42576205. Abstract CommentRecommendBookmarkWatch
